Compare OFIX & ASIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OFIX | ASIX |
|---|---|---|
| Founded | 1987 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 500.2M | 527.0M |
| IPO Year | 1998 | 2016 |
| Metric | OFIX | ASIX |
|---|---|---|
| Price | $12.03 | $20.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $17.25 | ★ $26.00 |
| AVG Volume (30 Days) | 274.2K | ★ 370.3K |
| Earning Date | 05-18-2026 | 05-22-2026 |
| Dividend Yield | N/A | ★ 3.47% |
| EPS Growth | ★ 29.39 | 11.11 |
| EPS | N/A | ★ 1.80 |
| Revenue | $822,312,000.00 | ★ $1,684,625,000.00 |
| Revenue This Year | $6.32 | $3.53 |
| Revenue Next Year | $6.01 | N/A |
| P/E Ratio | ★ N/A | $10.25 |
| Revenue Growth | 2.85 | ★ 45.49 |
| 52 Week Low | $10.25 | $14.10 |
| 52 Week High | $17.00 | $25.53 |
| Indicator | OFIX | ASIX |
|---|---|---|
| Relative Strength Index (RSI) | 29.82 | 63.42 |
| Support Level | $10.55 | $20.37 |
| Resistance Level | $16.50 | $21.87 |
| Average True Range (ATR) | 0.58 | 1.28 |
| MACD | -0.08 | 0.10 |
| Stochastic Oscillator | 6.71 | 88.88 |
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
AdvanSix Inc is a diversified chemistry company playing a critical role in international supply chains, innovating and delivering essential products for customers across a wide variety of end markets and applications that touch people's lives, including building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, and electronics. The company's key products include Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates. The majority of sales are from Plant Nutrients products. The company operates in the United States and internationally, with the majority of revenue coming from the United States.